All Companies
Ticker SPTX
Fewer than four quarters on file yet
You reached the page — here's exactly what SPTX is, and why it's out of scope for now.
What this ticker is
SPTX
Seaport Therapeutics, Inc.
NASDAQ
Healthcare
Biotechnology
United States
Mkt cap $1.3B
Seaport Therapeutics, Inc. is a clinical-stage therapeutics company focused on developing medicines for depression, anxiety, and other debilitating neuropsychiatric disorders. The company’s current pipeline is built around its proprietary Glyph platform, which is designed to advance orally administered therapies based on clinically validated mechanisms whil…
Why we can't analyze it yet
Fewer than four quarters on file yet: companyfacts on disk reach 2026-06-30 but the trailing set does not build (the last four quarters are not consecutive (gap or semi-annual filer)) — quarterly-lab case Found by the Foundation Sweep four-quarter pass 2026-09-11; held under the four-quarter coverage policy (2026-09-11) and released automatically once the pass resolves it.
Delvantic analyzes regular securities of single operating companies — one business with revenue, earnings and cash flows our valuation methods can assess bottom-up.
Reason code:
quarters_not_filed